PT86623A - Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles - Google Patents

Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles

Info

Publication number
PT86623A
PT86623A PT86623A PT8662388A PT86623A PT 86623 A PT86623 A PT 86623A PT 86623 A PT86623 A PT 86623A PT 8662388 A PT8662388 A PT 8662388A PT 86623 A PT86623 A PT 86623A
Authority
PT
Portugal
Prior art keywords
triazoles
alkylthio
aryl
derivatives
preparation
Prior art date
Application number
PT86623A
Other languages
English (en)
Other versions
PT86623B (pt
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT86623A publication Critical patent/PT86623A/pt
Publication of PT86623B publication Critical patent/PT86623B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT86623A 1987-01-27 1988-01-26 Processo para a preparacao de derivados de 3-aril-5-alquiltio-4h-1,2,4-triazol PT86623B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US706387A 1987-01-27 1987-01-27
US07/126,191 US4900743A (en) 1987-01-27 1987-12-04 3-aryl-5-alkylthio-4H-1,2,4-triazoles

Publications (2)

Publication Number Publication Date
PT86623A true PT86623A (pt) 1988-02-01
PT86623B PT86623B (pt) 1993-01-29

Family

ID=26676435

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86623A PT86623B (pt) 1987-01-27 1988-01-26 Processo para a preparacao de derivados de 3-aril-5-alquiltio-4h-1,2,4-triazol

Country Status (19)

Country Link
US (1) US4900743A (pt)
EP (1) EP0276793B1 (pt)
JP (1) JP2537651B2 (pt)
KR (1) KR960007166B1 (pt)
CN (1) CN1023480C (pt)
AR (1) AR244682A1 (pt)
AU (1) AU601013B2 (pt)
CA (1) CA1312605C (pt)
DE (1) DE3881712T2 (pt)
DK (1) DK171599B1 (pt)
ES (1) ES2058144T3 (pt)
FI (1) FI91526C (pt)
HU (1) HU205747B (pt)
IE (1) IE61188B1 (pt)
IL (1) IL85185A (pt)
NO (1) NO166642C (pt)
NZ (1) NZ223260A (pt)
PH (1) PH24513A (pt)
PT (1) PT86623B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2948189A (en) * 1987-12-31 1989-08-01 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
AU644500B2 (en) * 1990-12-20 1993-12-09 Merrell Dow Pharmaceuticals Inc. 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
DE4339412A1 (de) * 1993-11-18 1995-05-24 Bayer Ag Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen
AR032653A1 (es) * 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
CN1736381B (zh) * 2005-08-11 2010-09-08 沈阳药科大学 吗啉甲基萘满酮用于制备平滑肌解痉剂的用途
MX2011005981A (es) * 2008-12-12 2011-06-27 Astrazeneca Ab Nuevo proceso para preparar 4-[4-metil-5-(alquiltio c1-10/aril c5-10-alquilto c1-6)-4h-1,2,4-triazol-3-il]piridinas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193891B (en) * 1984-02-07 1987-12-28 Gyogyszerkutato Intezet Process for production of new derivatives of 1,2,4-triasole

Also Published As

Publication number Publication date
ES2058144T3 (es) 1994-11-01
AU601013B2 (en) 1990-08-30
JPS63201176A (ja) 1988-08-19
DE3881712D1 (de) 1993-07-22
KR880008999A (ko) 1988-09-13
FI880282A (fi) 1988-07-28
AU1072888A (en) 1988-07-28
JP2537651B2 (ja) 1996-09-25
NO880337L (no) 1988-07-28
NO880337D0 (no) 1988-01-26
PT86623B (pt) 1993-01-29
DK35488A (da) 1988-07-28
PH24513A (en) 1990-07-18
CN88100346A (zh) 1988-11-02
HU205747B (en) 1992-06-29
KR960007166B1 (ko) 1996-05-29
AR244682A1 (es) 1993-11-30
DK171599B1 (da) 1997-02-17
IL85185A (en) 1996-03-31
US4900743A (en) 1990-02-13
CA1312605C (en) 1993-01-12
EP0276793A2 (en) 1988-08-03
NO166642C (no) 1991-08-21
FI880282A0 (fi) 1988-01-22
NZ223260A (en) 1991-07-26
DE3881712T2 (de) 1993-12-23
NO166642B (no) 1991-05-13
DK35488D0 (da) 1988-01-26
FI91526C (fi) 1994-07-11
CN1023480C (zh) 1994-01-12
EP0276793A3 (en) 1988-09-21
HUT47257A (en) 1989-02-28
IL85185A0 (en) 1988-07-31
FI91526B (fi) 1994-03-31
IE61188B1 (en) 1994-10-19
EP0276793B1 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI884497A (fi) Menetelmä uusien, aromataasia inhiboivien 4(5)-imidatsolien valmistamiseksi
EP0302020A3 (en) Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl-amines
FI891338A (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
PT86800A (pt) Process for the preparation of erythromycin derivatives
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
PT87717A (pt) Process for preparing 2,4-thiazolidinedione derivatives
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
IL82858A0 (en) Process for the preparation of 1,2,5,6,9,10-hexabromo-cyclododecane
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
EP0297496A3 (en) Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
EP0371492A3 (en) Process for the preparation of 1,4-dihydropyridine derivatives
FI891111A (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI93010B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
FI92393B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
PT86829A (pt) Process for preparing thienothiopyran derivatives
FI883116A (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
NO922254L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO922253L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
KR970005015A (ko) 치환된 2,4-디아미노-5-시아노피리미딘 및 이들 화합물의 제조방법
GB2170805B (en) Process for the preparation of 3, 5-diamino-1, 2, 4-triazole derivatives
NO883525L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO913388L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO913422L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19910620

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031231